Clinical Trial Update: Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pembrolizumab with chemoradiation versus placebo in locally advanced head and neck squamous cell carcinoma completed; results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Head and Neck Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2023-06-08